Evaluation of Infection-Related Hospitalizations and Drug Prescriptions Among Sepsis Survivors in Germany

Carolin Fleischmann-Struzek; Bianka Ditscheid; Josephine Storch; Norman Rose; Melissa Spoden; Christiane S Hartog; Antje Freytag

doi:10.1001/jamanetworkopen.2022.20945

Evaluation of Infection-Related Hospitalizations and Drug Prescriptions Among Sepsis Survivors in Germany

JAMA Netw Open. 2022 Jul 1;5(7):e2220945. doi: 10.1001/jamanetworkopen.2022.20945.

Authors

Carolin Fleischmann-Struzek^{1

2}, Bianka Ditscheid³, Josephine Storch³, Norman Rose^{1

2}, Melissa Spoden⁴, Christiane S Hartog^{5

6}, Antje Freytag³

Affiliations

¹ Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
² Center for Sepsis Control and Care, Jena University Hospital/Friedrich Schiller University Jena, Jena, Germany.
³ Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.
⁴ Research Institute of the Local Health Care Funds (AOK), Berlin, Germany.
⁵ Department of Anesthesiology and Operative Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁶ Klinik Bavaria, Kreischa, Germany.

Abstract

This cohort study assesses infection-related hospitalizations and outpatient drug prescriptions among sepsis survivors in Germany and compares changes in hospitalization and prescription rates before and after sepsis occurrence.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Prescriptions
Germany / epidemiology
Hospitalization*
Humans
Sepsis* / drug therapy
Sepsis* / epidemiology
Survivors